A peer-reviewed article confirms that Qualigen’s FastPack® is

CARLSBAD, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) – Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing treatments for adult and pediatric cancers with orphan drug designation potential, announces today the publication of a study in the open source peer-reviewed journal, Diagnostic, validating the FastPack of the Company’s …

Read More »